Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
10/2002
10/03/2002US20020142961 As pharmaceuticals, diagnostics, biosensors and bioreactors
10/03/2002US20020142959 As drugs, diagnostics, biosensors and bioreactors
10/03/2002US20020142958 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/03/2002US20020142954 Laminin 15 and uses thereof
10/03/2002US20020142947 By muta-synthesis using a mutated micro-organism to influence the biosynthesis of at least one of the precursors of group B streptogramines; mutant strain employed is preferably derived from the strain S. pristinaespiralis SP92
10/03/2002US20020142467 Method for culturing recombinant cells
10/03/2002US20020142456 Protein for use in the treatment of body weight defects
10/03/2002US20020142448 Antibody for use in the diagnosis, treatment and prevention of bone disorders and cancer
10/03/2002US20020142447 DNA encoding the human serine protease EOS
10/03/2002US20020142446 DNA encoding the human serine protease EOS
10/03/2002US20020142445 Peptides for use in the treatment of tumors and graft versus host disease
10/03/2002US20020142444 AL-2 neurotrophic factor
10/03/2002US20020142440 Peptide for use in the diagnosis and treatment of inflammation, cancer, arteriosclerosis and degenerative disorders
10/03/2002US20020142435 Isolated human lipase proteins, nucleic acid molecules encoding human lipase proteins, and uses thereof
10/03/2002US20020142432 Human endosulfine gene
10/03/2002US20020142429 Elongation factor-2 kinase (EF-2 kinase) and methods of use therefor
10/03/2002US20020142424 Protein for use as a bioluminescent signaling tool
10/03/2002US20020142420 Cloned leptospira outer membrane protein
10/03/2002US20020142419 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of bone disorders and arthritis
10/03/2002US20020142414 Nucleotide sequences coding polypeptide for use in the treatment of lung defects, septic shock or inflammation
10/03/2002US20020142405 Process for the preparation of L-amino acids by fermentation and nucleotide sequences coding for the accDA gene
10/03/2002US20020142399 Generation of acidic lipase; obtain aspergillus, propagate, separate fungal biomas, recover fungal filtrate, separate ligase
10/03/2002US20020142398 Chemokine expressed in fetal spleen, its production and uses
10/03/2002US20020142394 Exonuclease-mediated gene assembly in directed evolution
10/03/2002US20020142392 Human melanocyte stimulating hormone receptor polypeptide and DNA
10/03/2002US20020142389 Soluble T cell receptor
10/03/2002US20020142388 Bacterial host strains
10/03/2002US20020142387 Methods for producing protein domains and analyzing three dimensional structures of proteins by using said domains
10/03/2002US20020142386 Engineering intracellular sialylation pathways
10/03/2002US20020142384 Generating soluble active recombinat proteins; obtain vector, insert preferential binding domain into vector, transform cell, propagate induce expresion of recombinant protein
10/03/2002US20020142378 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/03/2002US20020142376 Peptide for use in the diagnosis and treatment of nervous system disorders
10/03/2002US20020142374 Generating genetically engineered antibody with expanded half-life; obtain nucleotide sequences, insert segment coding preferential immunoglobulin fragment, recover protein
10/03/2002US20020142373 Tissue factor protein variants
10/03/2002US20020142371 Detecting target polynucleotides in a test sample; obtain sample, incubate with probe, detect signal, presence of signal indicates target sequences
10/03/2002US20020142370 Practical in vitro sialylation of recombinant glycoproteins
10/03/2002US20020142359 Monoclonal antibody to CEA, conjugates comprising said antibody, and their therapeutic use in an adept system
10/03/2002US20020142358 Antibody for use in the diagnosis, prevention and treatment of infections, multiple sclerosis, arthritis, autoimmune, inflammation and graft versus host disease
10/03/2002US20020142357 TNF receptor action modulation
10/03/2002US20020142356 Immunoassay for C-reactive protein
10/03/2002US20020142355 Methods for the in vivo biotin labeling of polypeptides
10/03/2002US20020142353 Connective tissue growth factor (CTGF) and methods of use
10/03/2002US20020142330 Novel glutamate receptor modulatory proteins and nucleic acid molecules and uses therefor
10/03/2002US20020142316 Mutants of the factor VII-activating protease and detection methods using specific antibodies
10/03/2002US20020142292 Mammalian genes; related reagents and methods
10/03/2002US20020141992 Deactivation of collagen receptors
10/03/2002US20020141991 Methods of treating inflammatory disease using antibodies which bind GPR-9-6
10/03/2002US20020141989 Antiinflammatory agents; antiallergens
10/03/2002US20020141988 Therapeutic agent for acute lung injury resulting from indirect causes comprising anti-il-8 antibody as active ingredient
10/03/2002US20020141982 Gene therapy methods using bone marrow-derived cells
10/03/2002CA2664797A1 Cytotoxic factors for modulating cell death
10/03/2002CA2504413A1 Methods and apparatus for gel-free qualitative and quantitative proteome analysis, and uses therefore
10/03/2002CA2443676A1 A novel modulator of non-genomic activity of nuclear receptors (mnar) and uses thereof
10/03/2002CA2442325A1 Shellfish protein
10/03/2002CA2442318A1 Antibodies against cancer
10/03/2002CA2442089A1 Nucleic acid molecules encoding a transmembran serine protease 9, the encoded polypeptides and methods based thereon
10/03/2002CA2442004A1 Microbial feeds for aquaculture and agriculture
10/03/2002CA2441721A1 Human potassium channel
10/03/2002CA2441706A1 A new essential downstream component of the wingless signalling pathway
10/03/2002CA2441700A1 Polypeptides and nucleic acids for bolekine
10/03/2002CA2441663A1 Viral vectors and their use in therapeutic methods
10/03/2002CA2441580A1 Coagulation factor vii derivatives
10/03/2002CA2441378A1 Nucleic acid molecules encoding serine protease cvsp14, the encoded polypeptides and methods based thereon
10/03/2002CA2441287A1 Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins
10/03/2002CA2440676A1 Transgenic animals expressing antibodies specific for genes of interest and uses thereof
10/03/2002CA2439961A1 Human cytokine receptor
10/03/2002CA2438206A1 Transporters and ion channels
10/03/2002CA2437287A1 Modified granulocyte colony stimulating factor (g-csf) with reduced immunogenicity
10/03/2002CA2436224A1 Cytotoxic factors for modulating cell death
10/03/2002CA2436208A1 A novel virus (cryptovirus) within the rubulavirus genus and uses therefor
10/03/2002CA2406527A1 Novel human stras-like protein and nucleic acids encoding the same
10/02/2002EP1245680A1 Gibberellin 2 beta-hydroxylase genes of rice and uses thereof
10/02/2002EP1245678A2 Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome
10/02/2002EP1245677A1 Nucleic acids and proteins of the mycoplasma hyopneumoniae mhp3 gene and uses thereof
10/02/2002EP1245676A1 Human monoclonal antibodies against tgf-beta ii receptor and medicinal use thereof
10/02/2002EP1245673A2 Efficient genetic suppressor elements
10/02/2002EP1244807A1 Il-6 like polynucleotide
10/02/2002EP1244799A1 Methods and materials relating to gene expression
10/02/2002EP1244798A2 Vectors capable of immortalizing non-dividing cells and cells immortalized with said vectors
10/02/2002EP1244797A1 Fusion protein delivery system and uses thereof
10/02/2002EP1244793A2 Serine/threonine kinase and serine protease polypeptides and nucleic acids encoding same
10/02/2002EP1244790A2 Nucleic acids encoding polypeptides having chips activity
10/02/2002EP1244789A2 Genes identified as required for proliferation of e. coli
10/02/2002EP1244784A2 Methods and compositions for inhibiting neoplastic cell growth
10/02/2002EP1244780A2 Dna encoding the human serine protease t
10/02/2002EP1244774A2 Pak5 a member of the p21-activated kinase (pak) protein family, nucleic acids and methods related to the same
10/02/2002EP1244773A1 Mutated hepatitis b virus, its nucleic and protein constituents and uses thereof
10/02/2002EP1244769A1 Production of peptides by fedbatch cultivation of a microorganism
10/02/2002EP1244705A2 Serpentine transmembrane antigens expressed in human prostate cancers and uses thereof
10/02/2002EP1244703A1 Novel abcb9 transporter and uses thereof
10/02/2002EP1244701A1 Transferrin polynucleotides, polypeptides, and antibodies
10/02/2002EP1244700A2 Vesicle trafficking proteins
10/02/2002EP1244695A2 Extracellular matrix and cell adhesion proteins as well as genes encoding them
10/02/2002EP1244692A2 Compositions and methods for detecting stress-inducible proteins
10/02/2002EP1244689A2 Cytokine polypeptides and nucleic acids
10/02/2002EP1244686A1 Transforming growth factor alpha hiii
10/02/2002EP1244685A1 Four disulfide core domain-containing (fdcd) polynucleotides, polypeptides, and antibodies
10/02/2002EP1244683A1 21 human secreted proteins
10/02/2002EP1244350A2 Prostatic cell line and use thereof to obtain an established prostatic cancer in an animal
10/02/2002EP1077068B9 Utilization of interferon alpha 5 in the treatment of viral hepatopathies
1 ... 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 ... 1125